quinoxalines has been researched along with ps1145 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adcock, IM; Caramori, G; Ito, K | 1 |
| Buccinnà, B; De Marco, G; Lomartire, A; Lupino, E; Piccinini, M; Ramondetti, C; Ricotti, E; Rinaudo, MT; Tovo, PA | 1 |
1 review(s) available for quinoxalines and ps1145
| Article | Year |
|---|---|
Anti-inflammatory inhibitors of IkappaB kinase in asthma and COPD.
Topics: Anti-Inflammatory Agents; Asthma; Heterocyclic Compounds, 3-Ring; Humans; I-kappa B Kinase; Imidazoles; NF-kappa B; Protein Serine-Threonine Kinases; Pulmonary Disease, Chronic Obstructive; Pyridines; Quinoxalines | 2004 |
1 other study(ies) available for quinoxalines and ps1145
| Article | Year |
|---|---|
In CD28-costimulated human naïve CD4+ T cells, I-κB kinase controls the expression of cell cycle regulatory proteins via interleukin-2-independent mechanisms.
Topics: Active Transport, Cell Nucleus; Antibodies, Monoclonal; Carrier Proteins; CD28 Antigens; CD3 Complex; CD4-Positive T-Lymphocytes; CDC2-CDC28 Kinases; Cell Cycle; Cell Cycle Proteins; Cell Proliferation; Cyclin D3; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Gene Expression; Gene Expression Regulation; Heterocyclic Compounds, 3-Ring; Humans; I-kappa B Kinase; I-kappa B Proteins; Imidazoles; Interleukin-2; Interleukin-2 Receptor alpha Subunit; Intracellular Signaling Peptides and Proteins; Lymphocyte Activation; NF-kappa B; NF-KappaB Inhibitor alpha; Oncogene Proteins; Protein Kinase Inhibitors; Pyridines; Quinoxalines; S-Phase Kinase-Associated Proteins; Signal Transduction; Up-Regulation | 2010 |